Life-threatening babesiosis in an asplenic patient treated with exchange transfusion, azithromycin, and atovaquone

Heart and Lung: Journal of Acute and Critical Care

Volumn 27, Issue 6, 1998, Pages 424-428

  Bonoan, José T ^b   Johnson, Diane H ^b   Cunha, Burke A ^a  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; AZITHROMYCIN;

ADULT; ARTICLE; ASPLENIA; BABESIA MICROTI; BABESIOSIS; CASE REPORT; DISEASE ASSOCIATION; DISEASE SEVERITY; EXCHANGE BLOOD TRANSFUSION; FATALITY; FEMALE; HEMOLYSIS; HUMAN; PARASITEMIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TICK BORNE DISEASE; TREATMENT PLANNING;

EID: 0031760840     PISSN: 01479563     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0147-9563(98)90089-9     Document Type: Article

References (7)

1. Lermi A, Cunha BA. Babesiosis. Infectious Disease Practice 1998;22:12-4.
2. Boustani MR, Gelfand JA. Babesiosis. Clin Infect Dis 1996; 22:611-5.
3. Bonoan JT, Cunha BA. Babesiosis. Emerg Med 1997;26:103-4.
4. Kim N, Rosenbaum GS, Cunha BA. Relative bradycardia and lymphopenia in patients with babesiosis. Clin Infect Dis 1998;26:1218-9.
5. Rosenbaum GS, Johnson DH, Cunha BA. Atypical lymphocytes in babesiosis. Clin Infect Dis 1995;20:203-4.
6. Hughes WT, Oz HS. Successful prevention and treatment of babesiosis with atovaquone. J Infect Dis 1995;4:1042-6.
7. Shaio MF, Kang KD. Response of babesiosis to a combined treatment of quinine and azithromycin. Transactions of the Royal Society of Tropical Medicine and Hygiene 1997;91: 214-5.